Literature DB >> 8023012

Type- and group-specific polymerase chain reaction for adenovirus detection.

P Pring-Akerblom1, T Adrian.   

Abstract

We report on a 1,551-base-pair-long DNA sequence, encoding the variable region and parts of the flanking conserved regions of the human adenovirus type 8 (AV8) hexon, and a sequence comprising 1,404 base pairs, encoding the corresponding regions of the human adenovirus type 31 (AV31). Comparison of the hexon sequences showed that the major sequence changes were located in loops I1 and I2 of the hexon polypeptides which form the surface of the virion. We established a type-specific polymerase chain reaction (PCR), using a combination of a group-specific (general) primer, located in a conserved region of the hexon gene, and type-specific primers located in the region that encodes for loop I2 of the AV8 (subgroup D), AV31 (subgroup A) and AV40 and 41 (both subgroup F) hexon polypeptides. We performed PCR directly from several different clinical specimens or from isolates (AV31). Type-specificity was confirmed by restriction analysis. We also carried out several PCR directly from faecal specimens, using a group-specific primer pair and compared the sensitivity of PCR with that of electron microscopy and enzyme immuno assay.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8023012     DOI: 10.1016/s0923-2516(07)80004-5

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  20 in total

1.  Rapid typing of human adenoviruses by a general PCR combined with restriction endonuclease analysis.

Authors:  A Allard; B Albinsson; G Wadell
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 2.  Diagnosis of viral and chlamydial keratoconjunctivitis: which laboratory test?

Authors:  E M Elnifro; R J Cooper; P E Klapper; A S Bailey; A B Tullo
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

3.  PCR and restriction endonuclease analysis for rapid identification of human adenovirus subgenera.

Authors:  E M Elnifro; R J Cooper; P E Klapper; A S Bailey
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Multiplex PCR assay for rapid identification of oculopathogenic adenoviruses by amplification of the fiber and hexon genes.

Authors:  Urmila Banik; Arun Kumar Adhikary; Eiko Suzuki; Toshiki Inada; Nobuhiko Okabe
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

5.  Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy.

Authors:  Ijad Madisch; Gabi Harste; Heidi Pommer; Albert Heim
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Quantitative detection and rapid identification of human adenoviruses.

Authors:  Rika Miura-Ochiai; Yasushi Shimada; Tsunetada Konno; Shudo Yamazaki; Koki Aoki; Shigeaki Ohno; Eitaro Suzuki; Hiroaki Ishiko
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

7.  Evaluation of PCR assays in presence of antibody to thermostable DNA polymerases for detection of microbial agents: avoiding false negative results for specimen containing low-titer agent.

Authors:  S K Poddar; M H Sawyer; J D Connor
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

8.  Detection and significance of adenoviruses in cases of sudden infant death.

Authors:  T Bajanowski; P Wiegand; R Cecchi; P Pring-Akerblom; T Adrian; G Jorch; B Brinkmann
Journal:  Virchows Arch       Date:  1996-05       Impact factor: 4.064

9.  Rapid detection of oculopathogenic adenovirus in conjunctivitis.

Authors:  Maysaa El-Sayed Zaki; Ghada A Abd-El Fatah
Journal:  Curr Microbiol       Date:  2007-11-06       Impact factor: 2.188

10.  Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues.

Authors:  L Crawford-Miksza; D P Schnurr
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.